BDX bcal diagnostics limited

Ann: Australian Patent Accepted for BREASTEST Technology, page-3

  1. 325 Posts.
    lightbulb Created with Sketch. 235

    More down ramping...


    1. It was stated in the last update that NATA approval is a few weeks late due to a few minor clarifications so we could get this approval any day now.


    2. Close to $10m in cash (see below from quarterly)


    3. Insiders (Jayne - CEO) buying $50k on market last week. I could not refuse this gift of 10c and 10.5 cents and took more of the same.


    4. Key foundational Patents approved for Australia in the last few days.


    5. When we do see the announcement of NATA approval, diagnostic partnerships will no doubt fall into place. I was at a GP recently for some genetic testing of which the Dr pulled out the sonic healthcare handbook to write the pathology paperwork and to give me details of cost etc. This will be huge if Bcal was bankrolled by Sonic at some point and Breasttest appears in this reference and offering.


    Exciting times to come with very astute management who have taken over 70 of these tests to market prior to breast test.


    https://hotcopper.com.au/data/attachments/6615/6615908-7aa2dc7a39b142fd85661755571375a3.jpg
    https://hotcopper.com.au/data/attachments/6615/6615913-75716ddeeaea6eb94797e6f200819ab9.jpg
    https://hotcopper.com.au/data/attachments/6615/6615918-fb83235503f1d5e738d095c0b7b05b43.jpg

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
6.9¢
Change
0.000(0.00%)
Mkt cap ! $25.25M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 22058 6.8¢
 

Sellers (Offers)

Price($) Vol. No.
6.9¢ 5714 1
View Market Depth
Last trade - 16.21pm 23/07/2025 (20 minute delay) ?
BDX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.